Patient P-02441

Synthetic patientMETA-24 · Day 168 · 35–44 · M · baseline S11Steering view · 3D Open companion preview

Therapy response

Improving

Tolerance

Favorable

GI state

Favorable

Inflammatory state

Improving

Nutritional resilience

Favorable

Discontinuation risk

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 META-24 started — Baseline state S11
Day 98 SC-12 recommended — Supportive Compound SC-12
Day 99 Patient accepted — Started SC-12 in the companion
Day 105 GI symptom burden −14% vs expected — Supportive Compound SC-12
Day 111 Tolerance state changed — Unstable → Improving

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days

Inflammatory activity-8
GI instability-4
Treatment adherence+4
Toxicity+2

What helped?

Supportive Compound SC-12Day 98
Result: symptom burden −14%

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes

Wearable

45 min

stable · -1.4 vs previous 14 d

Sleep duration

Wearable

7.8 h

stable · -0.0 vs previous 14 d

Energy level

Daily log

7.7/10

stable · +0.2 vs previous 14 d

Steps

Wearable

3,974

stable · -132 vs previous 14 d

GI burden

Companion

8.5/100

improving · -1.2 vs previous 14 d

Adherence

Companion

95.9 %

stable · +3.0 vs previous 14 d

Sleep quality

Wearable

66.9/100

stable · -0.5 vs previous 14 d

Glucose, CGM daily mean

CGM

126 mg/dL

stable · +1.5 vs previous 14 d

This trajectory is doing well — what to keep, what to watch

Steering view →

Heading towards restoration · 90 from the failing basin, 16 from restoration.

Good elements to keep

Supportive Compound SC-12
intervention · steering +23.9
Butyrate producers intact
hidden · steering +7.5
Protein (supports)
perturbation · steering +7.1
Daily walks resumed
perturbation · steering +3.3
Protein
supporter · GI -4.3 next day

Main detractors to watch

Bacteroides fragilis elevated
hidden · steering -7.4
Alcohol
perturbation · steering -3.8
Poor-sleep week
perturbation · steering -3
Low-HRV stretch
perturbation · steering -2.7
Alcohol
detractor · GI +2.5 next day

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Protein
-4.3supporter · 95%
Alcohol
+2.5detractor · 69%
Simple carbohydrates
-2.1no signal · 48%
Dietary fat load
-1.3no signal · 36%
Insoluble fibre
+1.3no signal · 31%
Histamine load
-0.8no signal · 18%
Ultra-processed food
+0.5no signal · 15%
Caffeine
+0.1no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Inflammatory signalling ↓20
- MicrobiomeBacteroides fragilis expansion
Autonomic recovery ↑20
- Wearable3,974 steps/day

DNA

Fictional pharmacogenomic panel

CYP2D6 Normal metabolizer
Expected exposure
GLP1R rs6923761 A
Altered receptor sensitivity

Microbiome

Shannon diversity 4.2 · butyrate capacity 80/100

Akkermansia muciniphilaNormal
Faecalibacterium prausnitziiNormal
Bacteroides fragilisHigh
Bifidobacterium longumLow
EnterobacteriaceaeNormal

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 64 ms
Sleep: 8.0 h
Steps: 3,743
Resting HR: 66 bpm

Daily log: GI score 9, nutritional resilience 71, adherence 96.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Keep fibre steady; no new sources this week
Eat slowly and stop at comfortable fullness — smaller volume, more often

What to do

Log the daily check-in; one line is enough
A 15-minute walk after lunch
Keep the sleep window steady
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the dose at the same time relative to your evening meal
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-02555	36%	S01	AD-05	no change	79
P-02031	33%	S12	AD-05	improved	47
P-02638	33%	S01	BR-03	improved	41
P-02462	40%	S12	DT-01	improved	65
P-02218	39%	S01	DT-01	improved	61
P-02565	38%	S09	DT-01	no change	79
P-02586	38%	S18	DT-01	improved	56
P-02491	34%	S09	DT-01	no change	65
P-02518	34%	S17	DT-01	improved	68
P-02126	33%	S16	DT-01	improved	59
P-02235	33%	S14	DT-01	improved	50
P-02685	33%	S16	DT-01	improved	47